Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX)

NCT03053193 is registered in ClinicalTrials.gov with Agendia as lead sponsor.

NCT NCT03053193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03053193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX)
Lead sponsor
Agendia
Phase
Observational
Overall status
Recruiting
Start date
April 28, 2017
Completion date
December 31, 2037
Enrollment
30,000 (estimated)
Sites
134

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer